The organs of the adult reproductive system can undergo extensive remodelling, experiencing rapid changes in tissue mass and function. Much of this matrix remodelling is attributed to the action of matrix metalloproteinases. Matrix metalloproteinase family members are expressed in a highly-regulated manner in many reproductive processes, including menstruation, ovulation, implantation, and uterine, breast, and prostate involution. Metalloproteinase concentrations and activity can be regulated by reproductive hormones, as well as by growth factors and cytokines that participate in reproductive events. In addition to playing a role in the loss of connective tissue mass, the metalloproteinases can influence the phenotype of the cellular components of the tissues, altering basic cellular functions such as proliferation, differentiation, and apoptosis. This review focuses on the expression of matrix metalloproteinases in reproductive tissues, and discusses the evidence supporting a role for these enzymes in modulating the structure and function of reproductive organs.
Introduction
described. Next is an examination of the regulation of MMP expression in reproductive organs. Finally, we evaluate how The reproductive organs are distinctive in their requirement MMPs function in reproductive tissues, discussing their influfor dramatic alterations in structural and functional properties ence on cell growth, death, and differentiation. We contend throughout adult life. These changes, which are orchestrated that the MMPs contribute to the ability of reproductive organs by hormones and frequently mediated by local growth factors to respond rapidly and dramatically to hormones, local growth and cytokines, involve extensive remodelling of connective factors, and cytokines. tissues. Connective tissue constitutes a large portion of the body, contributing to organ shape and volume. It is separated from epithelia by basement membrane (BM), and is composed
The matrix metalloproteinase family of the stromal elements: extracellular matrix (ECM), blood and lymph vessels, and cellular components, including
The MMP family is a group of structurally-related proteins fibroblasts and macrophages. The structural proteins of the that degrade ECM and BM components in a zinc-dependent ECM and BM are varied and include fibrillar proteins (e.g. manner at a physiological pH (for review, see Birkedal-Hansen collagens and elastin), proteoglycans, and multidomain glycoet al., 1993; Powell and Matrisian, 1996) . They are produced proteins (e.g. fibronectin and laminin). In addition to its role as proenzymes and secreted into the ECM, where they are in cell shape, the ECM plays a dynamic role in metabolic activated by proteolytic cleavage. All MMPs contain three processes, influencing cellular proliferation, differentiation, fundamental domains (Table I ; for reviews, see Birkedaland apoptosis, and serving as a repository for biologically active Hansen et al., 1993; Powell and Matrisian, 1996) . At the growth factors. Remodelling of connective tissue requires amino terminus is the 'pre' domain which signals for cellular both breakdown and resynthesis of ECM components. The export. Following is the 'pro' domain; the latent, or proMMPs, degradation of ECM proteins can be effected by a variety of are activated by cleavage and removal of this domain, in enzymatic activities, but the matrix metalloproteinases, or turn disengaging the cysteine in the conserved 'pro' domain MMPs, are believed to be primary contributors to this process sequence PRCGVPDV adjacent to the active site which binds as a result of several key features: they are secreted into zinc. This cleavage is performed by other MMPs, or in some extracellular space and function under physiological conditions; cases plasmin, and followed by a series of autocatalytic cuts they are highly regulated and frequently induced in areas of that result in active enzyme. The active site, whose amino active matrix remodelling; and members of this family are the acid consensus sequence is HEXGHXXGXXHS, is in the only enzymes capable of denaturing fibrillar collagens. This catalytic domain and holds a zinc ion by co-ordinate bonding review will focus on the expression and the function of MMP to the three histidines and a water molecule. MMP-7 is known family members in normal reproductive tissues. Following a as the 'minimal domain' MMP (see Table I ); its active form brief summary of the MMP family, the expression patterns of is~20 kDa and corresponds to the catalytic domain alone. In addition to the three fundamental MMP domains, MMP MMPs in the uterus, ovary, breast, testes, and prostate are Powell and Matrision, 1996) MMP Structure Substrates* H ϭ hinge domain; F ϭ furin consensus site; FN ϭ fibronectin-like domain; C ϭ collagen-like domain; TM ϭ transmembrane-like domain. *Actual substrates are precursor forms of urokinase-type plasminogen activator (uPA), tumour necrosis factor (TNF)-α, and MMP.
family members have domains that generate diversity in are protein-processing enzymes (Bresnahan et al., 1990) . In MMP-11, this sequence allows for internal cleavage of these their association with substrates and with cellular and matrix components (Table I ). All MMPs, with the exception of MMPMMPs, resulting in secretion of the enzyme in an activated form (Pei and Weiss, 1995) . 7, contain a haemopexin-like domain, which has been shown to be involved in mediating associations with ECM components Substrate specificity of MMP family members is broad and diverse. For example, MMP-3, MMP-7, and MMP-10, and inhibitors (for example, see Allan et al., 1991; DeClerck et al., 1993; Baragi et al., 1994) . The haemopexin domain is members of what has been called the stromelysin subclass, can cleave many ECM components, including proteoglycans, connected to the catalytic domain through a short but variable hinge region that assists in substrate specificity: its presence fibronectin, collagens, and gelatins. MMP-11, also a stromelysin, is a weak protease, thus far shown to cleave laminin and in the collagenases enables them to cleave fibrillar collagen (Hirose et al., 1993) . The gelatinases, MMP-2 and MMP-9, fibronectin (Murphy et al., 1993) . The collagenases, MMP-1, MMP-8, and MMP-13, target primarily fibrillar, but also nonpossess fibronectin-like sequences within their catalytic domains that facilitate gelatin binding by these enzymes. In fibrillar, collagens. In the rodent, the collagenase commonly referred to as MMP-1 due to its substrate specificity is actually addition, MMP-9 contains a small region that is reminiscent of α-2(V) collagen; its role in MMP-9 function is unclear. The more homologous to the human MMP-13 (Gack et al., 1995) . To avoid confusion in nomenclature, this review will refer to transmembrane-type (MT)-MMPs contain a transmembrane domain near their carboxyl termini which localizes the enzymes the rodent homologue as 'collagenase'. The gelatinases, MMP-2 and MMP-9, are potent in their ability to cleave denatured to the plasma membrane Takino et al., 1995; Will and Hinzmann, 1995; Puente et al., 1996) . In collagens. A recent report has revealed that MMP-2 can also cleave native collagen I (Aimes and Quigley, 1995). addition to the transmembrane domains, the MT-MMPs (MMPs 14-17) and MMP-11 contain a short region after their 'pro' Metalloelastase (MMP-12) targets elastin in particular, and, to a lesser extent, fibronectin (Shapiro et al., 1992) . Finally, the domains that fits the consensus cleavage site for furins, which four MT-MMPs (MMPs 14-17), are new additions to the We will then move to expression patterns of MMPs during MMP family, and thus far MMP-2 is the only known substrate implantation, pregnancy and post-partum involution. for MMP-14 and MMP-16 Takino et al., Cycling primate endometrium 1995; Will and Hinzmann, 1995; Puente et al., 1996) . In
The primate endometrium undergoes dramatic tissue sloughing addition to ECM components, MMPs can cleave precursor and remodelling during the menstrual cycle. Due to their forms of other MMPs, the serine protease urokinase-type degradative effects on the extracellular matrix, MMPs have plasminogen activator, protease inhibitor α-1-antitrypsin, and been heavily studied in this model system. Several MMPs are tumour necrosis factor (TNF)-α (Table I) .
highly expressed during menstruation, where the vast majority Natural inhibitors of MMPs can be divided into tissue and of tissue breakdown occurs. In general, MMP concentrations plasma inhibitors. The tissue inhibitors of metalloproteinases decline to low or undetectable values during the remainder of (TIMP), are currently represented by four members: TIMP-1, the menstrual cycle, and are particularly low in the endomet-TIMP-2, TIMP-3, and TIMP-4, have been described (Pavloff rium as it prepares for implantation. Figure 1 provides Birkedal-Hansen et al., 1993 for review; Shi overview, while Table II is a detailed compendium of MMP and et al., 1996) . TIMPs in general are widely expressed; they are TIMP expression patterns in human and monkey endometrium frequently, but not always, regulated in co-ordination with during the menstrual cycle. MMPs. TIMP-1 and TIMP-2 bind in a 1:1 ratio to the active Using samples taken directly from the intact endometrium sites of all MMPs. There is also TIMP interaction with latent during the menstrual cycle, expression of MMP-1, MMP-2, MMPs, with TIMP-1 preferentially binding proMMP-9, and MMP-3, MMP-7, MMP-9, MMP-10, MMP-11, TIMP-1, TIMP-2 binding proMMP-2. TIMP-3 and TIMP-4 are not as TIMP-2, and TIMP-3 has been identified at various stages in well characterized but have been shown to have MMP inhibitthe primate endometrium (see Table II and references therein). ory activity (Pavloff et al., 1992; Shi et al., 1996) . In addition MMP expression is most dramatic during the menstrual phase, to their MMP inhibitory activity, TIMPs have been implicated with MMPs produced in abundance. Generally, MMP-2 is in processes involving cell growth. For example, TIMP-1 expressed at relatively constant values thoughout the entire has long been associated with erythroid-potentiating activity menstrual cycle. During the proliferative phase, MMP-11 and (Docherty et al., 1985) , and has growth-factor-like activities MMP-7 are expressed in moderate abundance, while MMP-1, in some cell types (Hayakawa et al., 1994) . In addition, TIMP-MMP-3, and MMP-9 are expressed at low levels focally. MMP 1 has been reported to be part of a complex that can stimulate expression in general declines in early secretory phase, and steroidogenesis in the testes and ovary (Boujrad et al., 1995) . reappears in the late secretory stage. TIMP-1 and TIMP-2 are The second group of MMP inhibitors are the plasma α-also found throughout the menstrual cycle. TIMP-3 has only macroglobulins (Birkedal-Hansen et al., 1993 for review) .
been detected at the mid-secretory phase of the cycle, although MMPs rapidly cleave these proteins, changing their conformamenstrual tissue is yet to be examined. tion and resulting in covalent binding of inhibitor to MMP.
Cellular localization of the MMP family members by These complexes are then bound to receptors, internalized, in-situ hybridization and immunohistochemistry has also been and destroyed by cells throughout the body.
performed on samples taken from intact cycling endometrium. While these assays do not determine the activity of the enzymes, the location of the message or protein may indicate
MMP expression in reproductive organs
a potential function for these genes. MMP-1 is restricted to the In the following sections, we explore in detail the spatial and stromal components of the endometrium during the menstrual temporal patterns of MMP expression in reproductive tissues:
phase of the cycle with weakly positive cells also found during the uterus, ovary, breast, testes, and prostate. In general, the the proliferative phase (Table II) . MMP-1 mRNA has been MMPs are synthesized by connective tissue cells residing in found at or around arterioles and small vessels and in stromal the stroma of reproductive organs. This includes resident cells at the periphery of shedding menstrual fragments in the fibroblasts, endothelial cells in newly-forming vessels, and functional layer of the endometrium, extending from the infiltrating cells such as macrophages and neutrophils. An superficial zone and toward the entire functionalis as menstruexception is MMP-7, which is secreted primarily by cells of ation proceeds. These results suggest that MMP-1 is ultimately epithelial origin (Wilson and Matrisian, 1996) . This distinction involved in tissue breakdown during menstruation. The cellular in cell-type expression suggests that stromal and epithelial distribution of the stromelysins is quite similiar. MMP-3, MMPs may play different functional roles.
MMP-10, and MMP-11 mRNA appear to be confined to the stromal components of the endometrium. Protein expression Uterus of MMP-3 has also been associated with areas of stromal disruption during menstruation. These data support a role for The production of MMPs in the uterus has been studied using collagenases and stromelysins in the destruction of stromal observations made from both in-vitro culture systems and ECM during the menstrual phase of the cycle. Indeed, recent samples taken directly from the intact uterus. Using both organ culture work by Marbaix et al. (1996) reveals that model systems, expression patterns and enzyme activities have inhibitors specific to MMPs block ECM degradation induced been clearly mapped throughout the uterine cycle for several by steroid hormone removal. MMPs. Thus, we will first address MMP expression in the cycling uterus, followed by studies of cultured uterine cells.
The presence of migratory cells in the endometrium has been well established (Clark, 1992) , with endometrial granular and glandular epithelium of the functionalis, and not the basalis. This suggests that matrilysin does not induce sloughing, lymphocytes increasing during menstruation (Bulmer et al., but perhaps degrades luminal debris and subsequently facilit-1987). A recent immunohistochemistry study localized MMPates tissue remodelling during the early and mid-proliferative 9 protein to PMN, monocyte-macrophages, and eosinophils, phases. suggesting that these cells are the major source of MMP-9 in
The ratio of activated MMPs to their inhibitors plays a key menstrual tissues. In other studies, MMP-9 has also been role in regulating MMP activity. TIMP-1 mRNA has been immunolocalized to neutrophils in this tissue (Salamonsen and localized to both stromal and epithelial cells throughout the . These results explain the relative paucity of cycle (Table II) , and the protein is concentrated around blood MMP-9 transcripts but abundant enzymatic activity observed vessels in the sheep uterus, suggesting a protective effect on in primate endometrial tissues (Table II ; L.A.Rudolph and the integrity of blood vessel membranes. TIMP-2 is expressed R. Brenner, unpublished data) .
during the menstrual cycle, but its cellular localization is Unlike other MMPs, which are expressed by stromal cells, currently unknown. TIMP-3 mRNA is expressed only during MMP-7 is an epithelial-specific MMP (Wilson and Matrisian, the middle to late secretory phase, exclusively in the stroma. 1996). MMP-7 mRNA and protein have been localized to endometrial glandular epithelial cells during most phases of Uterine in-vitro culture systems the menstrual cycle. Brenner et al. (1996) reported that
The culturing of endometrial tissue, either as full explants or as isolated stromal or epithelial cells, has assisted in delineating matrilysin is detectable only after menses begins, in the luminal Irwin et al., 1996 MMP-3 stroma (low levels) Rodgers et al., 1994; Jeziorska et al., 1996 MMP-7 glandular epithelium (mid and late phase) Rodgers et al., 1993 supernuclear regions of GEC; PMN and Jeziorska et al., 1996 Brenner et al., 1996 MMP-9 PMN and monocytes/macrophages, stroma Rodgers et al., 1994; Jeziorska et al., 1996 (focal) MMP-10 stroma Rodgers et al., 1994; Brenner et al., 1996 MMP-11 stroma Rodgers et al., 1994 Brenner et al., 1996 TIMP-1 epithelium and periglandular stroma Rodgers et al., 1994; Hampton et al., 1995 TIMP-2 not determined Hampton and Salamonsen, 1994 PMN ϭ neutrophils; GEC ϭ glandular epithelial cells; TIMP ϭ tissue inhibitor of metalloproteinase; BM ϭ basement membrane.
the tissue specificity of MMP family members. In addition, it MMPs appears to be consistent with their decreased expression during the secretory phase of the cycle. has provided a system for examining the mechanisms controlling their expression.
The expression of MMP-1, MMP-2, MMP-3, MMP-9, and MMP-11 (Osteen et al., 1994; Rawdanowicz et al., 1994 ; Cultured explants of endometrial (Marbaix et al., 1992 (Marbaix et al., , 1995 Martelli et al., 1993; Osteen et al., 1994; Bruner et al., Schatz et al., 1994a,b) are also detected in human endometrial stromal cells cultured separately, as revealed by immunoblot, 1995) and uterine (Tyree et al., 1980) tissue, which contain a mixed population of epithelial and stromal cells and are immunoprecipitation, and northern analysis. Ovine endometrial stromal cells also synthesize and release MMP-1, MMP-2, and generally representative of proliferative endometrium, secrete MMP-1, MMP-2, MMP-3, MMP-7 and MMP-9, consistent MMP-3 in culture . MMP-1 and MMP-3 are produced primarily upon stimulation by with their expression during this phase in vivo (Table II) . Many of these MMPs were identified through their artificial phorbol myristate acetate (PMA), whereas MMP-2 expression has been shown to be constitutive (Salamonsen et al., 1991 , activation by 4-aminophenyl mercuric acetate (APMA), their activities on collagen or gelatin substrate gels, their dependence 1993). The expression of MMP-3 is reduced by the addition of various progestins to the media (Osteen et al., 1994 ; Schatz on zinc, and their inhibition by TIMP. TIMP-1 and TIMP-2 were also detected using this model system (Marbaix et al., et al., 1994a (Marbaix et al., et al., , 1995b . These results confirm the stromal localization patterns observed in vivo. The TIMP proteins can 1992). The addition of exogenous progesterone to explant cultures mimics the hormonal status of the endometrium during also be detected in culture medium from endometrial stromal cells , with TIMP-3 expression the secretory phase of the cycle. Physiological concentrations of progesterone reduce the protein expression and activity of increasing after progesterone addition (Higuchi et al., 1995) . In isolated endometrial epithelial cells, the cell-type specifi-MMP-1, MMP-2, MMP-3, MMP-7, MMP-9, and MMP-11 (Table III , see below); these effects are antagonized by the city of MMP-7 is retained. Interestingly, however, the addition of progesterone has no repressive effect, in contrast to the progesterone antagonist mifepristone (RU 38486) (Marbaix et al., 1992) . The reduction in the concentrations of these results obtained with explants and observed in vivo (Osteen Martelli et al., 1993; Schatz et al., 1994b; Osteen et al., 1994; Bruner et al., 1995 TIMP ϭ tissue inhibitor of metalloproteinase; IL ϭ interleukin; EGF ϭ epidermal growth factor; TNF ϭ tumour necrosis factor; TGF ϭ thyroid growth factor; IFN ϭ interferon; FSH ϭ follicle stimulating hormone.
et Bruner et al., 1995) . Bruner et al. (1995) have the highly invasive first-trimester trophoblasts secreting greater demonstrated that the presence of stromal cells is required to amounts of both gelatinases when compared with third-trimesmediate the down-regulation of MMP-7 expression following ter cells (Polette et al., 1994; Shimonovitz et al., 1994) . MMPprogesterone addition. Progesterone treatment of human endo-2 has been localized to the stromal compartment of floating metrial explants results in increased transforming growth factor villi cells, with strong labelling in close contact to the tropho-β (TGF-β) expression by the hormone-responsive stromal blastic basement membrane (Polette et al., 1994) , and also in cells. TGF-β represses MMP-7 production by the epithelial syncytiotrophoblasts (Fernandez et al., 1992) . In pre-eclampsia, cells, as demonstrated by reversal of this effect in the presence cytotrophoblast invasion is shallow and uterine arteriole of TGF-β neutralizing antibodies.
invasion is nearly absent. MMP-9 expression is dramatically reduced in cytotrophoblasts isolated from pre-eclamptic plaImplantation centas, suggesting a necessity for this MMP during the invasion In order to invade the uterine stroma, trophoblast cells must process (S.Fisher et al., unpublished) . degrade uterine BM and ECM. Therefore, enzymes such as Animal model systems have been used extensively to study the MMPs that target BM and ECM components have been the process of implantation due to the accessibility of tissue investigated during the process of implantation (Cross et al., at all times during trophobast invasion. Investigators have 1994 for review; Figure 1 ; Harvey et al., 1995b) .
recently detected strong expression of MMP-9 in the invading Investigators have determined that human trophoblasts protrophoblasts of the mouse, while MMP-2 mRNA was absent duce both MMP-2 and MMP-9 (Autio- Harmainen et al., 1992;  from all cells in the implantation region, including trophoblasts Fernandez et al., 1992; Polette et al., 1994; Shimonovitz et al., 1994; Canete-Soler et al., 1995; Reponen et al., 1995) , with and stromal cells of the decidual tissue (Canete-Soler et al., 1995; Reponen et al., 1995) . MMP-11 mRNA was localized 1992). Cultured human fetal membrane explants obtained from Caesarean sections up-regulate proMMP-1, proMMP-3 and to trophoblastic cells at the junction of embryonic and maternal proMMP-9, but not proMMP-2, when treated with human tissues (Lefebvre et al., 1995) , while MMP-1 and MMPrelaxin (X. Qin et al., unpublished) . Amnion epithelial cells 3 have been detected in the murine blastocyst (Brenner secrete MMP-2 in culture, suggesting that these cells are et al., 1989) .
responsible for the MMP-2 detected in second trimester amni-TIMP-1 and TIMP-2 mRNA and protein are also expressed otic fluid (Lehtovirta and Vartio, 1994) . MMP-1 and MMP-2 by human decidual cells during the first and third trimesters are also present in whole fetal membranes, but at relatively of pregnancy. TIMP-1 is localized to the stromal compartment consistent values before, during, and after labour (Fernandez of the decidua, and TIMP-2 is expressed in the trophoblast et al., 1992; Bryant-Greenwood and Yamamoto, 1995; Lei cells of floating villi (Polette et al., 1994 Reponen et al., 1995) .
the amniotic epithelium and the amniotic and chorionic ECM, TIMP-3 expression has been observed in fetal extravillous with the chorionic cytotrophoblast cells adjacent to the chortrophoblasts that have invaded the maternal decidual tissues, ionic ECM staining the strongest (X. Qin et al., unpublished) . as well as in the maternal decidual cells (Higuchi et al., 1995;  MMP-3 and MMP-9 expression in human amniochorion, and Reponen et al., 1995) . Observations that TIMP-3 expression MMP-9 in rat amnion, have been shown to increase with the is up-regulated by progesterone (Higuchi et al., 1995) suggests onset of labour, then decline after delivery (Bryant-Greenwood that TIMP-3 in particular may play a critical role in the and Yamamoto, 1995; Draper et al., 1995; Lei et al., 1995 ; control of trophoblast invasion, potentially by limiting ECM Vadillo-Ortega et al., 1995) . MMP-9 mRNA and protein are degradation. In vitro, the presence of TIMPs has been found localized in human amnion epithelium underlying macrophages to completely inhibit cytotrophoblast invasion (Graham and and chorion laeve trophoblast and decidual cells after labour Lala, 1991; Lala and Graham, 1991; Librach et al., 1991; (Vadillo-Ortega et al., 1995) . This timing of expression suggests Behrendtsen et al., 1992) . These studies emphasize that a that while many MMPs are expressed in the fetal membrane, balance between TIMP and MMP expression can strongly only MMP-3 and MMP-9 are associated specifically with the influence the invasion process.
preparation of labour.
Much of the work on trophoblast invasion has been done
In the maternal tissues, MMP-2 mRNA concentrations in using in-vivo model systems. However, establishment of the decidua rise throughout gestation, while MMP-10 mRNA in-vitro culture systems has also been successful. Cultured is detected only at term (Waterhouse et al., 1993) . During early human embryos secrete MMP-2 (Puistola et al., 1989; Graham pregnancy, TIMP expression levels are high, with maximal et al., 1993) , which increases upon addition of fibronectin concentrations of TIMP-1 mRNA at midgestation in the uterus, (Turpeenniemi-Hujanen et al., 1995) . Maximal enzyme concendecidua, and placenta of the mouse. Similarly, in the placenta, trations occur at days 4-5 of culture, corresponding with the TIMP-2 shows a seven-fold increase after day 14 in the mouse. time of implantation in vivo (Turpeenniemi-Hujanen et al., In contrast, TIMP-2 expression in the uterus, decidua, and 1992). Cultured trophoblasts have also been shown to secrete amnion increases steadily throughout pregnancy (Waterhouse MMP-2 and MMP-9 (Librach et al., 1991; Shimonovitz et al., et al., 1993; Hampton et al., 1995) . Even though the peak of 1994; Turpeenniemi-Hujanen et al., TIMP-1 expression correlates with the most invasive period 1995; Vagnoni et al., 1995) . Production of MMP-9 by human of embryo development, mice with a null mutation in the gene cytotrophoblasts and murine blastocysts has been found to be encoding TIMP-1 have normal fertility (reviewed in Cross the rate-limiting step of the invasive process in tissue culture et al., 1994) . These data suggest that TIMP-1 is not a models (Librach et al., 1991; Behrendtsen et al., 1992) . In critical inhibitor during pregnancy, or that there is sufficient addition, interleukin (IL)-1-β stimulates production of MMP-9, redundancy in the system to allow pregnancy to proceed while glucocorticoids decrease the production of this enzyme. It normally. has been suggested that normal trophoblast invasion may be At parturition, cervical ripening involves remodelling to regulated by the opposing actions of IL-1-β and glucocorticoids ensure uncomplicated delivery. The uterine cervix is composed (Librach et al., 1994) .
primarily of connective tissue, made up of fibrillar collagen Pregnancy and parturition and proteoglycans (Kleissl et al., 1978) . Several investigators The human fetus is surrounded by a membrane, the amniochohave implicated collagenase in cervical ripening (Rajabi et al., rion, that isolates it from the external environment. The 1988; Osmers et al., 1990 Osmers et al., , 1992 ; Rechberger and Woessner, amniochorion usually spontaneously ruptures during normal 1993; Mushayandebvu and Rajabi, 1995) . In fact, collagenase labour, but in many pathological conditions it may rupture concentrations are 6-23 times higher in cervices of humans prematurely. Rupture of the fetal membranes at term was (Rechberger and Woessner, 1993; Rajabi et al., 1988) and originally thought to be caused by a mechanical force generated guinea pigs (Rajabi et al., 1991b) in labour than at term, and by the myometrium with the onset of cervical dilatation are associated with a collagenase-mediated degradation of type (Benirschke and Kaufmann, 1990) . However, enzymatic I collagen in the cervical ECM (Rajabi et al., 1991a) . In degradation of the collagenous extracellular matrix of the fetal addition, collagenase is elevated in the blood at the time of membranes has been proposed as the mechanism that facilitates parturition (Rajabi et al., 1985 (Rajabi et al., , 1988 . Rajabi et al. (1991a) reported that collagenase production in primary monolayers of this process (Vadillo-Ortega et al., 1990; McGregor and French, cervical cells derived from 50 day pregnant guinea pigs key targets for natural selection, it follows that there may be considerable redundancy in the contributions of MMP family was controlled by progesterone, oestrogen, and prostaglandin members to reproductive processes. Interestingly, however, intermediates. These same investigators have separated stromal MMP-3 and MMP-10 mRNAs are strongly upregulated in and epithelial cervical cells, and have determined that the the stroma of the MMP-7 nullizygous post-partum uterus origin of collagenase secretion is the stromal cells. Interestingly, (C.L. Wilson and L.M.Matrisian, unpublished) . This suggests cervical epithelial cells secrete factors that stimulate stromal that other MMPs are somehow stimulated to counteract the cell collagenase production (Rajabi and Singh, 1995) . However, absence of MMP-7. in vivo, the increase in collagenase has been attributed to
In addition to MMP-1 and MMP-7, other MMP mRNA invading leukocytes, rather than cervical fibroblasts (Osmers expression patterns have been investigated during the process et al., 1991, 1992) .
of rodent uterine involution (Rudolph and Matrisian, 1994) . Post-partum involution MMP-1, MMP-2, MMP-3, MMP-11 and TIMP-1 are relatively The rodent post-partum uterus represents a dramatic example constant throughout involution, while MMP-7 and MMP-10 of rapid and extensive matrix remodelling characterized by are abundant during early involution, then taper off to low or abundant expression of MMPs. The involuting uterus undetectable levels by 4.5 days of involution (Rudolph and undergoes a rapid reduction in size as it returns to the pre- Wilson et al., 1995) . Many of these same pregnancy state which is primarily due to the loss of collagen MMPs are present in the murine uterus during the oestrous (Harkness and Moralee, 1956 ). Degradation of the principle cycle, with MMP-7 and MMP-11 elevated periodically throughcollagen of this organ, type I collagen, requires the action of out the cycle (L.A.Rudolph and L.M.Matrisian, unpublished). collagenases. While collagenase is produced in the rat uterus during post-partum involution, it is not expressed in the Ovary prepartum or non-pregnant uterus (Jeffrey and Gross, 1970;  Normal ovarian function, in particular ovulation and luteolysis, Blair et al., 1986; Rudolph and Matrisian, 1994) . During involves considerable tissue remodelling. For oocyte release uterine involution, however, the perinuclear region of the to occur, the follicle must be ruptured. This requires degradation smooth muscle cells of the myometrium show collagenase of the membrane propia between the thecal and granulosa staining by immunohistochemistry. Measurement of collacell layers, as well as disruption of the extracellular matrix genase bound to uterine collagen revealed that it is produced throughout the site of rupture. Following ovulation, the follicle only as needed and not stored, either intra-or extra-cellularly involutes and forms the corpus luteum. Also during this time, (Blair et al., 1986) . basement membrane disruption allows capillary growth into The peptide bonds between residues Gly 775 and Ile 776 of the the granulosa layer (Lipner, 1988) . Luteolysis, degeneration α-1(I) chain of native collagen are cleaved by the collagenases, of the corpus luteum and reformation into the corpus albicans, and mutations in this region make collagen resistant to these is another example of remodelling. These processes would be enzymes (Liu et al., 1995) . Mice carrying this mutation in the expected to involve protease action. endogenous α-1(I) gene developed normally, although in adult MMP involvement in ovulation has been well demonstrated mice the skin became thickened. More dramatically, post- (Figure 1 ), particularly for MMP-1. Throughout ovulation, partum involution of the uterus was markedly impaired, with MMP-1 protein is found in the theca interna and externa, the a significant reduction in the number of litters, and the presence interstitial glands, and germinal epithelium (Tadakuma et al., of dense, collagenous nodules in post-partum uteri. These 1993). As ovulation approaches, collagenase activity is concenresults suggest that cleavage of type I collagen at the Gly 775 / trated at the site of future rupture: collagen concentrations Ile 776 site is required for remodelling of the ECM in the postdrop, while MMP-1 protein and activity increase in the partum uterus.
capillary lumina at the apex of the follicle (Murdoch and The activity of rat MMP-7 was first identified during early McCormick, 1992; Tadakuma et al., 1993) . In addition, specific involution of the uterus (Sellers and Woessner, 1980) , and inhibitors of collagenase block ovulation (Butler et al., 1991) . was later purified and characterized from this same source After follicle rupture, MMP-1 protein is found in granulosa (Woessner and Taplin, 1988; Abramson et al., 1995) . Recently, and thecal cells around the orifice (Tadakuma et al., 1993) . the mouse homologue of MMP-7 was cloned and the mRNA MMP-2 protein and activity increase as ovulation approaches expression pattern during uterine involution examined (Wilson (Puistola et al., 1986; Russell et al., 1995 Russell et al., ). et al., 1995 . Consistent with the previously reported activity Ewes immunized against the α43 subunit of inhibin exhibit of this enzyme, MMP-7 mRNA is abundant during early poor oocyte release and abnormal follicular involution, which uterine involution, then tapers off to undetectable amounts by correlates with decreased concentrations of preovulatory MMP-4.5 days of involution. In addition, murine MMP-7 mRNA 2 (Russell et al., 1994 2 (Russell et al., , 1995 . has been detected at low levels in the adult virgin and pregnant During luteolysis, active forms of the gelatinases MMP-2 uterus (Wilson et al., 1995) . Although MMP-7 is the only and MMP-9 are induced (Endo et al., 1993) . One active form known epithelial-specific MMP, mice with a null mutation in of MMP-2 that is present in the corpus luteum is the 46 kDa the gene encoding MMP-7 proceed normally through the size, which is neither bound nor inhibited by TIMP-2 (Fridman oestrus cycle, pregnancy, and uterine involution (C.L. Wilson et al., 1992; Russell et al., 1995) . An interesting possible et al., unpublished; L.A.Rudolph and L.M.Matrisian, mechanism for MMP activation during this time was proposed by Endo et al. (1993) : collagenases are known to be activated unpublished). Because agents that affect reproduction are by hypochloride (HOCl) and chloramine. These molecules morphology is similar to a normal 9-12 day pregnant gland. In fact, glands from transgenic virgin mice express mRNA for can be generated by macrophage and neutrophil peroxidases β-casein, a milk protein, at amounts similar to those of glands utilizing hydrogen peroxide (H 2 O 2 ), whose concentration from normal 9-10 day pregnant mice (Sympson et al., 1994 ; increases in the corpus luteum during luteolysis. Witty et al., 1995b) . These data suggest that overexpression Consistent with a balance in expression of MMPs and their of MMP-3 in mammary epithelial cells alters lobular alveolar inhibitors, TIMP and α-2-macroglobulin proteins are present development. in human follicular fluid (Curry et al., 1988) . Specifically,
The major phase of mammary growth and differentiation during ovulation and luteal development in rats, TIMP-1 occurs during pregnancy and lactation. The mammary gland concentrations are high in granulosa cells where the basement consists of two types of epithelial cells, luminal epithelial cells membrane is disrupted, and in thecal cells (Chun et al., 1992;  and myoepithelial cells. Luminal mammary epithelial cells Nothnick et al., 1995) . The TIMP-1 gene is active again in make up the inner lining of ducts and alveoli involved in the late luteolysis (Nothnick et al., 1995) . TIMP-2 concentrations synthesis and passage of milk products via the nipple. The do not change during ovulation in rat, although bovine TIMPmyoepithelial cells are the contractile elements for milk expul-2 mRNA increases during luteolysis (Juengel et al., 1994;  sion, as well as for the production of ECM components. Nothnick et al., 1995; Smith et al., 1995) . TIMP-3 is present Several investigators have suggested that the mammary gland during early luteolysis (Nothnick et al., 1995) , 1982) . Several MMPs have been implicated in the the mammary gland occur during ductal development, lactation, degradation and remodelling of the ECM during mammary and involution. Once again, the MMPs have been implicated gland involution. MMP-2 and MMP-3 are detected by day 4 in the dramatic changes that take place in the mammary gland of involution, and maintain their expression until day 10 during these processes. (Dickson and Warburton, 1992; Talhouk et al., 1992; , Temporal expression of several MMP family members 1994). MMP-11 is detected three days after weaning and correlates with normal ductal branching morphogenesis that persists at low levels for~2 weeks (Lefebvre et al., 1992) . MMP-3 and MMP-11 have been localized to fibroblasts around occurs during the development of the murine mammary gland.
the degenerating ducts of postlactational mouse mammary At 5-10 weeks of age, when the mammary ducts are actively glands (Lefebvre et al., 1992; Talhouk et al., 1992; Fang et al., growing and branching, MMP-2 and MMP-3 (Talhouk et al., 1995) , while MMP-2 and MMP-3 have been immunolocalized 1991; Witty et al., 1995b) are detected at high concentrations, to mammary myoepithelial cells (Dickson and Warburton, then decrease by 13 weeks of age. MMP-11 and TIMP-1 1992; Li et al., 1994) . Degradation of the ECM by MMPs is mRNAs are also detected during this time period, but at much likely to reduce the volume of connective tissue in the organ. lower concentrations (Witty et al., 1995b) . MMP-3 has been Degradation of the BM, however, may play an even more localized by in-situ hybridization to the stroma surrounding critical role in mammary gland involution. BM is considered the growing mammary duct, but not to the region around the a survival factor for mammary epithelial cells, and loss of terminal end bud (Witty et al., 1995b) . This localization pattern contact with the BM results in apoptosis (Boudreau et al., of MMP-3 suggests a role in matrix repair after ductal growth 1995; Witty et al., 1995a; Pullan et al., 1996) . has occurred. MMP-7 gene expression has also recently been TIMPs have also been detected during the involution process, detected in the cycling, lactating and involuting murine mamwith peak expression at 4-6 days of involution (Talhouk et al., mary gland (Wilson et al., 1995) and atrophic non-lactating 1992; Li et al., 1994) . When slow-release TIMP pellets were human mammary gland (Saarialho-Kere et al., 1995) .
surgically implanted into murine mammary glands, involution Recent studies have indicated a potential role for the MMPs, was delayed. These results, combined with the MMP expression particularly MMP-3, in the reorganizational events that occur data, support the hypothesis that the balance of ECM-degrading during mammary development. Transgenic mice with MMPenzymes and their inhibitors regulates the rate of remodelling 3 under the control of the whey acidic protein (WAP) (Sympson of the basement membrane, and consequently, the tissueet al., 1994) or the mouse mammary tumour virus (MMTV) specific function of the mammary gland (Talhouk et al., 1992) . (Witty et al., 1995b) 
promoters exhibit alterations in normal
Male reproductive system branching and lactation. At 10-13 weeks of age, the mammary glands from the transgenic animals appear more mature, with Testes additional branches from primary and secondary ducts filling Little is known of MMP expression in the testes, yet there exists some evidence that points toward a role in maturation the spaces within the ductal network. This altered mammary and progression of sperm through testicular passages. MMPpipe cleaner', meaning that it potentially keeps ducts clear by cleaving other secreted proteins which may cause blockage. 7 has been detected in epithelial cells of the efferent ducts, Indeed, MMP-7 secretion into the lumen of glandular elements and the initial and caudal segments of the epididymis of the has also been observed by immunohistochemistry (W.C.Powell, adult mouse (Wilson et al., 1995) . MMP-2 is expressed by C.L. Wilson and L.M.Matrisian, unpublished data) . cultured rat Sertoli cells (Sang et al., 1990a,b) . TIMP-1 and TIMP-2 have been detected in rat Sertoli cells of the maturing testis (Ulisse et al., 1994) .
Regulation of MMPs in reproductive tissues
The fertilins, a member of the ADAMs (A Disintegrin And
In the reproductive system, hormones, growth factors, and Metalloproteinase domain) family of proteins, are involved in cytokines play critical roles in regulating organ and cellular several aspects of male reproductive function (Wolfsberg et al., functions. It is provocative that these agents also regulate 1995). Besides possessing transmembrane and disintegrin-like MMP and MMP inhibitor expression in ways consistent with domains, these proteins share motifs with MMPs: they contain a role for metalloproteinase activity as a downstream effector 'pre' and 'pro' domains, and a putative zinc-dependent metalloof these biological signals. Table III provides specific examples proteinase region. They are expressed in spermatogenic cells, of MMP regulation in the reproductive tissues. with different ADAM family members localized to different MMP regulation by hormones, growth factors, and cytokines meiotic stages along the seminiferous tubules. It is postulated has largely been associated with changes in the rate of gene that these ADAMs may aid in migration of spermatids and transcription. A key player in the induction of most MMP spermatozoa through the tubules (Wolfsberg et al., 1995) .
promoters is the transcription factor AP-1. Recognition sites Other ADAMs are believed to be involved in sperm-egg for this factor are found in the promoters of most MMP family fusion (Wolfsberg et al., 1993) .
members (Crawford and Matrisian, 1996 for review). AP-1 is Prostate composed of members of the Jun and Fos early response The prostate represents another reproductive tissue that proteins, which are induced rapidly and strongly by signal undergoes extensive morphological changes throughout life, transduction cascades from tumour promoters, growth factors, with maturation and involution representing periods of tissue and oncogenes. AP-1 is required for the expression of many construction and remodelling. In young male rats, the prostate MMPs, since transcription from MMP promoters with mutated begins to mature shortly after birth, and differentiation is AP-1 sites is greatly reduced (Crawford and Matrisian, 1996) . complete by~50 days of age. In the maturing prostate and
The MMP-2 promoter is set apart from the others; it appears seminal vesicles, Wilson et al. (1992) found a calciumto be more of a housekeeping promoter, rather than an inducible dependent gelatinolytic activity of 64 kDa, most likely active one, since it is GC-rich and lacks AP-1 sites (Huhtala et al., MMP-2. Interestingly, the timing of this gelatinase activity 1990). Indeed, MMP-2 does tend to be constitutively expressed, coincides with the period of differentiation of each structure although it can be enhanced or repressed to some extent in the prostatic complex.
(see below). Similar to other reproductive organs, the prostate undergoes In addition to control at a transcriptional level, MMPs involution upon hormone, in this case androgen, withdrawal.
can be regulated post-transcriptionally by changes in mRNA This process involves extensive apoptosis and ECM degradation stability, and post-translationally by cleavage and removal of (Kyprianou and Isaacs, 1988) . Apoptosis peaks 2-3 days after the propeptide and interaction with inhibitors ; castration in the rat; by day 4 there have been considerable Delany and Brinckerhoff, 1992) . These mechanisms can play structural changes; and by 8 days involution is complete. Powell a role in controlling MMP concentrations in response to et al. (1996) have examined in detail the expression of MMP-7 reproductive hormones and factors, as further detailed below. and its relationship to rodent prostate involution. MMP-7 mRNA Control of MMPs in the cycling endometrium by is expressed in the epithelium beginning day 2, is at a maximum progesterone and oestrogen at day 5, and has dropped off by day 8. MMP-7 protein is maximal on day 5, and basal by 8 days following castration.
Hormonal regulation of MMP concentrations is perhaps best TIMP-1 expression closely follows: it peaks on day 5, and studied in the cycling endometrium. In particular, progesterone decreases to a plateau by days 6-8. Also found in the involuting is a potent repressor of MMP concentrations both in vivo and prostate is a calcium-dependent gelatinase, probably MMP-2, in vitro. It is tempting to conclude that progesterone is the key whose maximum expression is around day 7 postcastration (Wilregulator of MMP expression in the cycling uterus. For son et al., 1991) . Based on their patterns of expression, these example, the MMP genes are expressed during the times in MMPs may assist in the orchestration of tissue remodelling the cycle when progesterone concentrations are low, i.e. during involved in involution of the prostate.
the proliferative and menstrual stages of the uterus. During MMPs may also play a role in ensuring that ductal structures the secretory stage when progesterone concentrations are high, remain open. In adult human, MMP-7 is expressed in ductal the expression levels of most MMP family members decrease and secretory epithelial cells of exocrine organs, including the (see Table II ). Additionally, MMP-1, MMP-2, and MMP-3 prostate (Saarialho-Kere et al., 1995) . Because MMP-7 protein have been localized to stromal cells surrounding proliferative was not detected in the stroma beneath these epithelial cells, glandular epithelium, known to lack progesterone receptors Saarialho-Kere et al. concluded that it may be secreted into . An exception to this generality is MMP-2, which is the only MMP expressed at significant the lumen. Subsequently, they dubbed MMP-7 an 'enzymatic concentrations during the secretory phase of the cycle (Rodgers one is responsible for the increase in MMPs during menstruation. However, recent results from Salamonsen and Woolley et al., 1994; Brenner et al., 1996) .
(1996) and Brenner et al. (1996) indicate that progesterone Progesterone may not be the principal player in MMP reduction during the Progesterone regulation of MMP expression has been studied secretory phase. In particular, at the end of the proliferative extensively in cultured uterine cells and explants. In early studstage, MMP concentrations drop before progesterone concenies, Jeffrey et al. (1971) reported that progesterone inhibits trations rise. It is possible that MMP concentrations are initially collagenase activity in cultured rat uterine cells. They surmised influenced by growth factors, cytokines, or other hormones that the inhibition is at the level of collagenase expression, since (see below). Further investigation using in-vitro and in-vivo progesterone does not affect enzyme activity. Since that time, systems should elucidate the mechanisms by which hormones progesterone has been found to repress MMP-1, MMP-3, MMPand growth factors co-ordinately regulate MMP concentrations 7, MMP-9, and MMP-11 mRNA and/or protein in cultured to influence endometrial structure and function. endometrial tissues (Table III) . The mechanism of this inhibition Oestrogen is not well understood. Progesterone regulation of gene expres-
The effects of oestrogen on MMP expression are not well undersion has been shown to be mediated by direct binding of the stood. Certainly, it is an important element of the reproductive receptor to negative hormone-response elements in the prosystem: targeted deletion of the oestrogen receptor in mice results moters of many steroid-responsive genes (Gronemeyer, 1991) .
in infertile females, and reduced fertility in males (Lubahn et al. , An attractive hypothesis is that the MMPs are regulated in this 1993). In the rat, removal of all endogenous steroid hormones manner. While putative hormone-response elements have been by ovariectomy and adrenalectomy resulted in complete loss of identified in the promoters of MMP-1, MMP-3, and MMP-7 collagenase activity and synthesis in the rat uterus (Anuradha (Matrisian et al., 1985; Angel et al., 1987; Gaire et al., 1994), and Thampan, 1993) . Implantation of ostradiol wax pellets into there is no direct evidence that these elements respond to these rats brought about a recovery in synthesis of the enzyme progesterone. At least in the case of MMP-7, there appears to to pre-ovariectomized concentrations, suggesting that uterine be an indirect effect mediated through the paracrine activity collagenase is indeed under the regulatory influence of oestraof TGF-β. When treated with progesterone, human endometrial diol. Oestrogen has little effect on MMP expression in vitro, stromal cells upregulate their TGF-β production (Bruner et al., although in some cases oestrogen enhanced the inhibitory action 1995). TGF-β then represses MMP-7 production by co-cultured of progesterone on MMPs, presumably through its ability to upepithelial cells, potentially via TGF-β inhibitory elements regulate progesterone receptor production (Table III) . In part, (TIEs) that reside in the MMP-7 promoter. TIEs have previously this lack of effect may be a result of the requirement for an been demonstrated to be involved in TGF-β repression of oestrogenic environment for cell viability, thus reducing the MMP-3 expression in rat fibroblasts .
effects of exogenous hormone. Oestrogen has been shown to Progesterone may also modify MMP activity post-translastimulate transcription of c-jun, junB, and junD, components of tionally, at the level of activation, and by altering local AP-1, in the rat uterus (Nephew et al., 1994) . Since AP-1 is an concentrations of specific MMP inhibitors. For example, the important factor in the expression of MMPs (see above), the serine protease plasmin can activate, by 'pro' peptide removal, apparent failure of oestrogen to strongly affect MMP transcripmany MMP family members (Powell and Matrisian, 1996 for tion emphasizes the complexity of hormonal regulation of MMP review). Plasminogen activator inhibitor-1 (PAI-1) inhibits the gene expression. protease activity of members of the plasmin cascade (Blasi et al., 1990) , and progesterone stimulates production of PAIOther factors regulating MMP expression in repro-1 in cultured endometrial stromal cells (Casslen et al., 1992) .
ductive tissues Consequently, progesterone induction of PAI-1 may ultimately Three other pregnancy-associated hormones have been impliclead to a reduction in proMMP activation. In rabbit and human ated in regulation of MMPs (Table III and references therein) . cultured endometrial cells, TIMP-1 mRNA and protein are Relaxins, which are members of the insulin superfamily, are stimulated by progesterone (Marbaix et al., 1992) . Similarly, involved in connective tissue remodelling (Bryant-Greenwood, progesterone upregulates, in a dose-dependent manner, endo-1982) . In particular, several are expressed by the decidua and metrial TIMP-3 mRNA concentrations; RU486 blocks this placenta and are implicated in control of collagen degradation effect (Higuchi et al., 1995) . The overall inhibitory effect of that leads to fetal membrane rupture during the process of progesterone on MMP function in the endometrium may thus parturition (Bryant-Greenwood and Yamamoto, 1995) . Consistoccur by a combination of effects: repressing MMP expression, ent with this function, X. Qin et al. (unpublished) have shown blocking activation, and tipping the MMP/inhibitor ratio in that the expression of relaxin receptors coincides temporally favour of the inhibitors.
and spatially with that of MMP-1, and that relaxin H2 causes Additional findings from in-vivo studies of the cycling a dose-dependent increase in production of MMP-1, MMP-3, uterus remind us that in-vitro experiments are an aid to and MMP-9, but not MMP-2, by human fetal membrane understanding MMP expression in the uterus, but not the explants. Relaxin is also the putative signal for cervical whole story. Based on data obtained in cultured endometrial dilatation; it enhances MMP-1 activity in cultured guinea pig cells, it is logical to speculate that: (i) the rise in progesterone cervical cells. A second hormone, serotonin, may also be is responsible for the decrease in MMP expression during the involved in MMP induction after parturition. It is required for expression of collagenase in post-partum rat uterine smooth secretory phase of the cycle; and (ii) the decrease in progester-muscle cells. Wilcox et al. (1992) have determined that leads to activation of proMMP-9, gonadotrophin may indirectly serotonin exposure for 8-10 h induces maximal concentrations inhibit MMP-9 activity. of collagenase mRNA in these cells. They speculate that a Cytokines, produced by either local cells or infiltrating pulse of serotonin around the time of parturition may be inflammatory cells, may also regulate MMP concentrations sufficient to induce the amounts of collagenase necessary for and influence reproductive processes. TNF-α and IL-1 have post-partum involution of the uterus. Finally, interferon-tau, been implicated in control of MMP expression in the uterus the major protein product of preimplantation trophoblasts in (Table III) . In endometrial stromal cell culture, either TNF-I the ewe, inhibits expression of MMP-1 and MMP-3, but not or IL-1-α up-regulates, in a dose-dependent manner, the MMP-2, by endometrial stromal cells.
activities of MMP-1, MMP-3, and MMP-9, but not MMP-2. Glucocorticoids have also been shown to depress MMP IL-1-α also inhibits suppression of MMP-3 by progesterone values in reproductive tissues, and appear to act through a (E.Sierra-Rivera and K. Osteen, unpublished) . IL-1-β expresvariety of mechanisms. During involution of the mouse mamsion in the endometrium is normally weak (Tabibzadeh and Sun, mary gland, AP-1 and MMP-3 are up-regulated (Marti et al., 1992) . During pregnancy, however, human cytotrophoblasts 1994; Fang et al., 1995) . Dexamethasone, a synthetic glucocortexpress increasing amounts of IL-1-β and its receptors; this icoid, represses MMP-3 expression and inhibits involution expression correlates with both MMP-9 activity and the invas- (Fang et al., 1995) . The glucocorticoid receptor inhibits MMP-1 iveness of these cells in culture. Interestingly, IL-1-β also upand MMP-3 expression by interfering with AP-1 transactivation regulates trophoblastic expression of human chorionic gonadfunction, without affecting the latter's DNA binding ability otrophin (HCG), which inhibits MMP-9 activity. This further (Jonat et al., 1990; Yang-Yen et al., 1990; Konig et al., 1992) .
highlights the balance of inducers and suppressors inherent in Additionally, dexamethasone has been found to reduce the control of MMP activity. stability of MMP mRNA through a pathway that requires deWith regard to MMP inhibitors, TIMPs and α-2-macronovo transcription (Delany and Brinckerhoff, 1992) . In yet a globulin are induced in the ovary by progesterone (Table  third mechanism, glucocorticoids decrease expression of IL-III). While the anti-oestrogen tamoxifen does not affect this 1-β, and consequently MMP-9, in cultured human cytotrophoinduction, the antiprogesterone RU486 represses it (Mann blasts. In turn, this diminishes in-vitro invasion by these cells et al., 1993; Morgan et al., 1994) . In cultured rat granulosa (Librach et al., 1994) . cells, prolactin, which can inhibit proteolytic activity during Like glucocorticoids, epidermal growth factor (EGF) can ovulation, stimulates expression and activity of TIMP-1 but regulate both transcription and stability of MMP mRNAs has no effect on TIMP-3 (Murray et al., 1996) . In these same (McDonnell et al., 1990; Delany and Brinckerhoff, 1992 ; Gaire cells, LH and IL-1-β induce all three TIMPs, possibly via upet al., 1994) . EGF stimulates c-fos and c-jun (Muller et al., regulation of progesterone production (W.B. Nothnick and 1984; Quantin and Breathnach, 1988) , both of which are T.E. Curry, Jr, unpublished) . Finally, in Sertoli cells from required for MMP-3 induction by EGF in rat-1 fibroblasts the maturing rat testis, follicle stimulating hormone (FSH) (McDonnell et al., 1990) . EGF induction of MMPs may be stimulates TIMP-1 and TIMP-2 expression through a cAMPimportant for implantation events. Expression of EGF receptors dependent mechanism that results in increased binding of increases in uterine epithelial cells just prior to implantation AP-1 to the TIMP promoters (Ulisse et al., 1994) . (Harvey et al., 1995b) , and EGF has been shown to enhance invasion by human cytotrophoblasts in vitro (Bass et al., 1994) .
Roles of MMPs in cellular processes
In implanting mouse blastocysts, expression of MMP-9, which Throughout this review, we have described the expression of appears to play a crucial part in this process in humans MMPs and speculated on how they may function in reproductive (Librach et al., 1991; S.Fisher et al., unpublished) , increases processes. For example, MMPs appear to be important in the in the trophoblast giant cells. Addition of EGF to cultures of tissue degradation that occurs during menstration, and the use these cells at a time equivalent to implantation (day 7) increases of inhibitors or genetic manipulation support a role for MMP MMP-9 activity; there is no response to EGF by these cells 2 activity in ovulation and uterine and breast involution. Epithelial days later (Harvey et al., 1995a,b) .
MMPs may function in glands and ducts as 'enzymatic pipe Gonadotrophins appear to affect MMP proteolytic activity cleaners'. It is not always clear whether MMP expression is a by post-translational mechanisms (Table III) . Ovarian granulosa direct cause of connective tissue destruction, or more the result cells cultured on Matrigel in serum-free medium secrete MMPof an attempt to repair tissue already damaged. Along these lines, 9, degrade the Matrigel, and detach. When gonadotrophin is MMPs are expressed during cutaneous wound healing, a form added to the medium, TIMP-1 release increases. Consequently, of tissue remodelling (Saarialho-Kere et al., 1994) . Tissue gelatinase activity, Matrigel loss, and cell detachment decrease.
remodelling in any form can involve a variety of cellular events, On the other hand, while gonadotrophin does not alter TIMP including proliferation, migration, differentiation, and production in cultured human trophoblasts, it still inhibits apoptosis. MMPs may participate in these cellular activities in MMP-9 activity and reduces trophoblast invasion dramatica variety of ways. Through their actions, they can alter cellally. This phenomenon may be due to gonadotrophin's inhibimatrix and cell-cell interactions, change cell shape, and release tion of urokinase-type plasminogen activator (uPA), a member or activate growth factors. These are events which in turn can of the plasmin cascade (Yagel et al., 1993) . That is, by inhibiting a member of the protease cascade that potentially alter cellular processes, as detailed below.
Proliferation involution is understandable, their association with apoptosis is less clear. The prevailing hypothesis is that the BM is a survival The relationship between MMPs and cellular proliferation is factor for epithelial cells, and their loss of contact with the BM enigmatic. As discussed earlier, MMPs are induced by growth results in programmed cell death. In the breast, a BM rich in factors and oncogenes that also increase the proliferative index laminin is required for normal mammary gland development of cells in vitro. Indeed, MMPs such as MMP-7 can be found in and gene expression (Li et al., 1987; Lin and Bissell, 1993) . proliferative endometrium and are expressed in dividing cells, as When mammary epithelial cells are placed in culture without indicated by co-expression of the nuclear antigen Ki67 (Brenner the critical BM components, they undergo apoptosis (Boudreau et al., 1996) . However, in some cases, serum, a potent inducer Pullan et al., 1996) . The role of BM as a survival cell proliferation, can decrease MMP concentrations (Matrisian factor has been demonstrated by disruption of integrin/BM interet al., 1985, for example). Also, while ectopic expression of actions. For example, antibodies against β 1 integrins induce MMP-3 in the mammary glands of transgenic mice results in mammary epithelial cell apoptosis (Boudreau et al., 1995) , and accelerated epithelial cell growth, the rates of cellular differenti-α v β 3 antagonists cause apoptosis in endothelial (Brooks et al., ation and death are also increased (Sympson et al., 1994; Witty 1994) and melanoma ) cells. In vivo, the et al., 1995a . These contradictory results suggest that MMP overexpression of an activated form of MMP-3 in the mammary involvement in cellular proliferation, differentiation, and death gland of transgenic mice results in loss of BM components may not be easily separated. (Sympson et al., 1994) , and a marked disruption of BM structure The potential roles for MMPs in cellular proliferation are (Witty et al., 1995b) . Consistent with a role for MMPs in modunumerous. It is tempting to speculate that, at least in some cases, lating programmed cell death via alterations in the BM, these the induction of MMPs in proliferative tissues could facilitate mice show a significant increase in the apoptotic index in the clearing of basement membrane and/or connective tissue mammary tissue (Boudreau et al., 1995; Witty et al., 1995a) . matrix components to make room for the multiplying cells as Studies by Boudreau et al. (1995) shed some light on the they expand. In these cases, MMP induction may be part of a molecular pathways connecting cellular ligation to BM and programme of gene expression designed to prepare the tissue apoptosis. The expression of IL-1-β-converting enzyme (ICE), for growth. In other cases, changes in the structure or integrity the mammalian homologue of the C.elegans cell death-inducing of the basement membrane may alter the shape of the cell, ced-3 gene (Vaux et al., 1994) , correlates with the loss of ECM modifying gene expression patterns and stimulating cell growth and the induction of apoptosis in mammary epithelial cells in vivo (Ingber, 1990) . In addition, proteolysis of the ECM could result and in vitro (Boudreau et al., 1995) . Inhibitors of ICE activity in release of matrix-bound growth factors and their receptors, prevent apoptosis in cultured mammary epithelial cells plated in such as the FGF and heparin-binding epidermal growth factor the absence of basement membrane (Boudreau et al., 1995) . (EGF) (Vlodavsky et al., 1990 , Southgate et al., 1992 Lanzrein These results suggest that basement membrane ligation inhibits et Levi et al., 1996; Whitelock et al., 1996) , or growth ICE expression, and the loss of this contact results in elevated factor-like domains may be released from matrix proteins and ICE and induction of the apoptotic pathway. have growth-stimulatory effects (Panayotou et al., 1989) . A third It is also interesting to consider that MMPs may induce possibility is that MMPs can directly activate growth factors by apoptosis through alternative mechanisms. Fas interactions with processing them from precursor molecules. MMP-1, MMP-2, its ligand initiate apoptosis in T lymphocytes (Brunner et al., MMP-3, MMP-7, and MMP-9 activate TNF-α in this manner 1995; Ju et al., 1995) . Fas is a member of the TNF/nerve growth (Gearing et al., 1994) . Similarly, MMP-7 releases from highfactor receptor family (Suda et al., 1993) . MMPs have been molecular-weight urokinase-type plasminogen activator its implicated in the conversion of TNF-α and Fas ligand to active, receptor-binding amino-terminal fragment, which has been soluble forms (Gearing et al., 1994; Kayagaki et al., 1995) , shown to be mitogenic and to increase cell motility (Marcotte suggesting that MMPs activate or release factors involved in the et Odekon et al., 1992; Anichini et al., 1994) . MMPs apoptotic process. may thus affect cellular proliferation by a variety of indirect mechanisms.
Development and differentiation
The process of embryonic development is characterized by Apoptosis dramatic changes in tissue morphology and extensive matrix Many organs in the reproductive system undergo involution remodelling. MMP expression, however, is surprisingly in response to hormone withdrawal, including prostate, breast, restricted during this time (Matrisian and Hogan, 1990) . MMPuterus, and ovary. Involution of reproductive organs employs 1 and MMP-3 transcripts have been detected in preimplantation drastic reduction of tissue volume through ECM degradation, mouse embryos by reverse transcription-polymerase chain reacand loss of the cellular component by apoptosis (Kerr et al., tion (RT-PCR) (Brenner et al., 1989) . Later in development, 1972; Cunha et al., 1987; Kyprianou and Isaacs, 1988;  MMP-1 message and protein have been seen in embryonic bone Tenniswood et al., 1992; Juengel et al., 1993; Fang et al., 1995) . and skin (McGowan et al., 1994; Mattot et al., 1995) . MMP-7 MMP expression correlates with this resorption process (see mRNA has been detected in late-stage embryos only by RTabove), and the MMPs have been causally (albeit indirectly) PCR (Wilson et al., 1995) . MMP-9 mRNA has been reported to implicated in the involution of the breast (Talhouk et al., 1992) be restricted to developing bone (Reponen et al., 1994) , but and uterus (Liu et al., 1995) .
other studies demonstrate more widespread expression patterns (Canete-Soler et al., 1995) . MMP-2 mRNA expression in Although the involvement of MMPs in the loss of ECM during embryos contrasts with most of the other MMPs in that it is differentiation are likely to be a reflection of the complexity of the information that resides in BM and ECM and how that expressed in many tissues (Reponen et al., 1994) , perhaps again reflecting the differences between the MMP-2 promoter and that information is received and processed by the cell. Disruption of the matrix by MMPs could either eliminate specific signals, of the other MMP family members (Huhtala et al., 1990) . The relative scarcity of MMPs in developing embryos contrasts reveal cryptic signals, or even act to release or activate factors stored in the matrix that can in turn alter cellular function. Initial sharply with the abundant expression of MMPs in adult reproductive tissues undergoing equally rapid alterations in morstudies ablating MMP activities using gene targeting have just begun to address these issues. The next decade of research holds phology.
MMP activity has been implicated in branching ductal morexceptional promise for understanding the roles these enzymes play in reproductive function, and lead the way for the use of phogenesis in the salivary gland, the lung, and the mammary gland (Nakanishi et al., 1986; Ganser et al., 1991; MMP-related therapies in the treatment of reproductive dysfunction. Witty et al., 1995b) . Genetic ablation of the MMP-3 (J.S. Mudgett et al., unpublished) , MMP-7 (C.L. Wilson et al., unpublished) , and MMP-12 (Shipley et al., 1996) genes, how-
